Mar.29 — Julia Cheek, founder and CEO of EverlyWell Inc, discusses the importance of maintaining a wide-scale Covid-19 testing level in the U.S. to contain and track the disease despite the ongoing mass vaccination efforts. The provider of home testing kits is said to be valued at $2.9 billion after making its first two acquisitions. Cheek speaks to Emily Chang on “Bloomberg Technology.”
source
Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.
This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.